Skip to main content

Advertisement

Log in

AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background and aim

Acute-on-chronic liver failure (ACLF) is a severe form of alcoholic hepatitis (SAH). We aimed to study the natural course, response to corticosteroids (CS), and the role of the Asian Pacific Association for the Study of Liver (APASL) research consortium (AARC) score in determining clinical outcomes in AH patients.

Methods

Prospectively collected data from the AARC database were analyzed.

Results

Of the 1249 AH patients, (aged 43.8 ± 10.6 years, 96.9% male, AARC score 9.2 ± 1.9), 38.8% died on a 90 day follow-up. Of these, 150 (12.0%) had mild–moderate AH (MAH), 65 (5.2%) had SAH and 1034 (82.8%) had ACLF. Two hundred and eleven (16.9%) patients received CS, of which 101 (47.87%) were steroid responders by day 7 of Lille’s model, which was associated with improved survival [Hazard ratio (HR) 0.15, 95% CI 0.12–0.19]. AARC-ACLF grade 3 [OR 0.28, 0.14–0.55] was an independent predictor of steroid non-response and mortality [HR 3.29, 2.63–4.11]. Complications increased with degree of liver failure [AARC grade III vs. II vs I], bacterial infections [48.6% vs. 37% vs. 34.7%; p < 0.001); extrahepatic organ failure [66.9% vs. 41.8% vs. 35.4%; p < 0.001] respectively. The AARC score better discriminated 90-day mortality. Harrell’s C-index was 0.72 compared to other scores.

Conclusion

Nearly 4 of 5 patients with AH present with ACLF. Such patients have a higher risk of infections, organ failures, lower response to CS, and higher mortality. Patients with AH and ACLF with AARC grade 3 should be considered for an early liver transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

Data will be made available in excel format on request.

Abbreviations

AH:

Alcoholic hepatitis

SAH:

Severe alcoholic hepatitis

MDF:

Maddrey’s discriminant function

STOPAH:

Steroids or pentoxifylline for alcoholic hepatitis

CS:

Corticosteroids

MELD:

Model for end-stage liver disease score

GAHS:

Glasgow alcoholic hepatitis score

ACLF:

Acute-on-chronic liver failure

INR:

International normalized ratio

EASL-CLIF:

European study of liver (EASL.) Chronic liver failure

APASL:

Asian Pacific Association for the Study of the Liver

AARC:

Asian Pacific Association of Research Consortium

AST:

Aspartate aminotransferase

PaO2 :

Partial pressure of oxygen

FiO2 :

Fraction of inspired oxygen

MAH:

Moderate alcoholic hepatitis

Gr:

Group

HR:

Hazard ratios

CI:

Confidence intervals

C-index:

Concordance index

CRP:

C-reactive protein

EHOF:

Extrahepatic organ failure

CTP:

Child–Turcotte–Pugh

CLIF-SOFA:

Chronic liver failure-sequential organ failure assessment

NIAAA:

National Institute on Alcohol Abuse and Alcoholism

DNA:

Deoxyribonucleic acid

MAP:

Mean arterial pressure

References

  1. Thursz M, Morgan TR. Treatment of severe alcoholic hepatitis. Gastroenterology. 2016;150:1823–1834

    Article  PubMed  Google Scholar 

  2. Thursz MR, Richardson P, Allison M, STOPAH Trial, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015;23(372):1619–1628

    Article  Google Scholar 

  3. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo-controlled double-blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480–487

    Article  CAS  PubMed  Google Scholar 

  4. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–1354

    Article  CAS  PubMed  Google Scholar 

  5. Forrest EH, Atkinson SR, Richardson P, STOPAH trial Management Group, et al. Application of prognostic scores in the STOPAH trial: discriminant function is no longer the optimal scoring system in alcoholic hepatitis. J Hepatol 2018;68:511–518

    Article  PubMed  Google Scholar 

  6. Forrest EH, Atkinson SR, Richardson P, STOPAH Trial Management Group, et al. Prevalent acute-on-chronic liver failure and response to CS in alcoholic hepatitis. J Hepatol 2018;69:1200–1201

    Article  PubMed  Google Scholar 

  7. Louvet A, Labreuche J, Artru F, et al. Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology. 2015;149:398-406.e8

    Article  PubMed  Google Scholar 

  8. Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011;10(365):1790–1800

    Article  Google Scholar 

  9. Sarin SK, Choudhury A, Sharma MK, APASL ACLF Research Consortium (AARC) for APASL ACLF working Party, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int 2019;13:353–390

    Article  PubMed  Google Scholar 

  10. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(1426–37):1437.e1–9

    Google Scholar 

  11. Bajaj JS, O’Leary JG, Reddy KR, et al. survival in infection-related acuteon-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60:250–256

    Article  PubMed  Google Scholar 

  12. Sersté T, Cornillie A, Njimi H, et al. The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. J Hepatol 2018;69:318–324

    Article  PubMed  Google Scholar 

  13. Choudhury A, Jindal A, Maiwall R, APASL ACLF Working Party, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int 2017;11:461–471

    Article  CAS  PubMed  Google Scholar 

  14. Crabb DW, Bataller R, Chalasani NP, NIAAA Alcoholic Hepatitis Consortia, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology. 2016;150:785–790

    Article  PubMed  Google Scholar 

  15. Piano S, Singh V, Caraceni P, International Club of Ascites Global Study Group, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156:1368-1380.e10

    Article  PubMed  Google Scholar 

  16. Gustot T, Fernandez J, Szabo G, et al. Sepsis in alcohol-related liver disease. J Hepatol 2017;67:1031–1050

    Article  CAS  PubMed  Google Scholar 

  17. Vergis N, Atkinson SR, Knapp S, et al. In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection related and is associated with high circulating levels of bacterial DNA. Gastroenterology. 2017;152:1068-1077.e4

    Article  CAS  PubMed  Google Scholar 

  18. Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 2015;12:231–242

    Article  PubMed  Google Scholar 

  19. Sarin SK, Sharma S. Predictors of steroid non-response and new approaches in severe alcoholic hepatitis. Clin Mol Hepatol 2020;26:639–651

    Article  PubMed  PubMed Central  Google Scholar 

  20. Garcia-Saenz-de-Sicilia M, Duvoor C, Altamirano J, et al. A day-4 Lille model predicts response toCS and mortality in severe alcoholic hepatitis. Am J Gastroenterol 2017;112:306–315

    Article  CAS  PubMed  Google Scholar 

  21. Sharma S, Maras JS, Das S, et al. Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness. Sci Rep 2017;28(7):6816

    Article  Google Scholar 

  22. Maras JS, Das S, Sharma S, et al. Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome. Hepatol Commun 2018;16(2):628–643

    Article  Google Scholar 

  23. Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146:1231-1239.e1-6

    Article  PubMed  Google Scholar 

  24. Vergis N, Atkinson SR, Knapp S, et al. In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA. Gastroenterology. 2017;152:1068-1077.e4

    Article  CAS  PubMed  Google Scholar 

  25. Louvet A, Thursz MR, Kim DJ, et al. Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials. Gastroenterology. 2018;155:458-468.e8

    Article  CAS  PubMed  Google Scholar 

  26. Vergis N, Khamri W, Beale K, et al. Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase. Gut. 2017;66:519–529

    Article  CAS  PubMed  Google Scholar 

  27. Moreau R, Clària J, Aguilar F, CANONIC Study Investigators of the EASL Clif Consortium; Grifols Chair; European Foundation for the Study of Chronic Liver Failure (EF Clif), et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol 2020;72:688–701

    Article  CAS  PubMed  Google Scholar 

  28. Maiwall R, Bajpai M, Choudhury AK, AARC working Party, et al. Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC. Liver Int 2021;41:1083–1096

    Article  CAS  PubMed  Google Scholar 

  29. Arab JP, Díaz LA, Baeza N, et al. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study. J Hepatol 2021;75:1026–1033

    Article  PubMed  Google Scholar 

  30. Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol 2019;70(2):328–334

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

I would like to thank Dr Suman Pramanik and Pawan Kr. Singh for helping with the graphs and drafting of the manuscript, Mansi Singh and Ashini Kumar Hidam for retrieving the additional data.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

RM and SKS: made the concept and design of the study. RM: wrote the first draft with subsequent inputs by SSP, and SSP performed. SKS: Statistical analysis. All other authors contributed to the patients and approved the final version of the manuscript. Critical revision of the manuscript for important intellectual comments by SKS.

Corresponding author

Correspondence to Shiv Kumar Sarin.

Ethics declarations

Conflict of interest

Nothing to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maiwall, R., Pasupuleti, S.S.R., Choudhury, A. et al. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study. Hepatol Int 17, 662–675 (2023). https://doi.org/10.1007/s12072-022-10463-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-022-10463-z

Keywords

Navigation